Drug intelligence / Profile preview

hydrocortisone + sodium bituminosulfonate

Development stage
Unknown
Lead developer
Ichthyol-Gesellschaft Cordes, Hermanni & Co.
Modality
Small Molecules
Administration
Topical
01

Overview

Ichthocortin is a topical dermatological combination therapy developed by Ichthyol-Gesellschaft Cordes Hermanni & Co. It is formulated with hydrocortisone acetate, a mild (Class I) corticosteroid, and sodium bituminosulfonate (pale Ichthyol). Hydrocortisone provides anti-inflammatory, anti-allergic, and antipruritic effects by acting as an agonist at the glucocorticoid receptor, thereby suppressing the production of pro-inflammatory cytokines and mediators. Sodium bituminosulfonate, a substance derived from sulfur-rich oil shale, complements this action with its own anti-inflammatory, antimicrobial, and anti-seborrheic properties, which are thought to involve the inhibition of inflammatory mediator release and leukotriene synthesis. Ichthocortin is primarily indicated for the treatment of inflammatory, non-infectious skin conditions such as eczema and various forms of dermatitis where a low-potency corticosteroid is appropriate.

Brand names
Ichthocortin
Other names
Ichthocortin Cream
02

Targets

ALOX12 (Arachidonate 12-lipoxygenase, 12S type)GR (Glucocorticoid receptor)

Beyond the preview

Go deeper on hydrocortisone + sodium bituminosulfonate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on hydrocortisone + sodium bituminosulfonate.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call